Related Experiment Video
Updated: Jan 29, 2026
Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
Probiotics for treating acute diarrhea in children: an evidence synthesis
Cheng Chen1, Pei Liu2, Lang Xiao1
1School of Basic Medical Sciences, Chengdu Medical College, Chengdu, Sichuan, China.
Insights
Probiotics effectively reduce diarrhea duration and cases in children, offering a beneficial intervention for pediatric gastroenteritis. Specific strains like Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus show promising results in clinical trials.
Area of Science:
- Pediatric Gastroenterology
- Microbiome Research
- Evidence-Based Medicine
Background:
- Acute diarrhea is a major global cause of childhood illness and hospitalization.
- Effective treatments are crucial for reducing pediatric morbidity and mortality.
Purpose of the Study:
- To evaluate the efficacy of probiotics in treating acute diarrhea in children.
- To synthesize evidence from randomized clinical trials on probiotic interventions.
Main Methods:
- Systematic review and meta-analysis of 25 randomized controlled trials (RCTs) involving 9,071 children.
- Searched major databases (EMBASE, PubMed, Cochrane) up to September 2023.
- Analyzed outcomes including diarrhea duration, recovery rates, and hospitalization length.
Main Results:
- Probiotics significantly shortened diarrhea duration by approximately 1.21 days (SMD=-0.44).
- Reduced the number of diarrhea cases (RR=0.68) and stool frequency (SMD=-0.38).
- Lactobacillus strains showed specific benefits, with Limosilactobacillus reuteri reducing duration and Lacticaseibacillus rhamnosus decreasing case numbers.
Conclusions:
- Probiotics demonstrate clinical efficacy in managing pediatric diarrhea.
- They shorten illness duration, increase recovery, and reduce diarrhea incidence.
- Further research may refine strain-specific recommendations for optimal outcomes.
Objective:
We aimed to evaluate the efficacy of probiotics against diarrhea in children.
Background:
Acute diarrhea remains the leading cause of childhood morbidity and mortality worldwide and is one of the most common reasons for child visits and hospitalizations.
Methods:
Randomized clinical trials (RCTs) of probiotics for the treatment of acute diarrhea in children were identified by searching EMBASE, PubMed, the Cochrane Library, and the Clinicaltrials.gov registry with a search deadline of September 29, 2023. Fixed- and random-effects models were employed, using standardized mean differences (SMDs), relative risk ratios (RRs) and 95% confidence intervals (CIs) as outcome indicators. Primary outcomes included the duration of the child's diarrhea and the number of children with diarrhea at the completion of the trial, and secondary outcomes included the length of the child's hospitalization, the frequency of stools on day 2 post-intervention, and the number of recoveries within 3 days of the intervention. We performed this according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement.
Results:
The study included 25 randomized controlled trials involving 9,071 subjects. After the intervention, moderate evidence indicated that, probiotics shortened the duration of diarrhea in children (SMD=-0.44, 95% CI: -0.70∼-0.17), increased the number of children who recovered from diarrhea, reduced the number of children with diarrhea at the completion of the trial (RR = 0.68, 95% CI: 0.54∼0.86), and reduced the number of stools on d 2 (SMD=-0.38, 95% CI: -0.59∼-0.18), but the quality of evidence was very low. However, there was no effect on children's length of hospitalization (SMD=-0.27, 95% CI: -0.63∼0.09) and the number of recoveries within 3 d after the intervention (RR = 1.70, 95% CI: 0.98∼2.97). Among these, probiotics reduced the average duration of diarrhea by approximately 1.21 days. For the primary outcome, subgroup analyses based on individual probiotic strains, Limosilactobacillus reuteri was found to have a significant trend in reducing the duration of diarrhea (SMD=-0.62,95% CI:-0.92∼-0.32), while Lacticaseibacillus rhamnosus was found to have a significant trend in decreasing the number of children with diarrhea at the completion of the trial (RR = 0.52, 95% CI:0.37∼0.74).
Conclusion:
The results showed that probiotics demonstrated adequate clinical efficacy in shortening the duration of diarrhea, increasing the number of recoveries in children with diarrhea, reducing the number of diarrhea cases, and alleviating diarrhea symptoms.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/, PROSPERO CRD42024534039.
More Related Videos
Related Concept Videos
02:55The Evidence for Evolution
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:15Dehydration Synthesis
Dehydration synthesis (also called a condensation reaction) is the chemical process in which two molecules covalently link together to form a new molecule, along with the release of a water molecule. Many physiologically important compounds form by dehydration synthesis reactions, such as complex carbohydrates, proteins, DNA, and RNA.
Synthesis of carbohydrates
Sugar molecules are covalently linked together by dehydration synthesis. During the reaction, the hydroxyl (-OH) group from...
02:17Synthesis and Decomposition Reactions
01:59Lagging Strand Synthesis
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...
02:36Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...